Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
The Cochrane Database of Systematic Reviews|December 14, 2011
Interventions to improve adherence to antiretroviral therapy in children with HIV infectionDeborah Bain-Brickley, Lisa M Butler, Gail E Kennedy, et al.
AIDS and Behavior|October 19, 2016
Perinatal Depression Among HIV-Infected Women in KwaZulu-Natal South Africa: Prenatal Depression Predicts Lower Rates of Exclusive BreastfeedingEmily L Tuthill, Jennifer A Pellowski, Sera L Young, et al.
Molecular Cancer Research : MCR|June 8, 2022
Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in CancerJulia S Scott, Zeyad D Nassar, Johannes V Swinnen, et al.
The Prostate|January 18, 2014
Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkersIan R Johnson, Emma J Parkinson-Lawrence, Lisa M Butler, et al.
Endocrine-Related Cancer|September 17, 2004
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancerHoward I Scher, Grant Buchanan, William Gerald, et al.
The Journal of Pathology|October 11, 2013
Molecular pathology and prostate cancer therapeutics: from biology to bedsideDaniel Nava Rodrigues, Lisa M Butler, David Lorente Estelles, et al.
Molecular Cancer Research : MCR|July 30, 2015
Maximizing the Therapeutic Potential of HSP90 InhibitorsLisa M Butler, Roberta Ferraldeschi, Heather K Armstrong, et al.
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
New Opportunities for Targeting the Androgen Receptor in Prostate CancerMargaret M Centenera, Luke A Selth, Esmaeil Ebrahimie, et al.
Plos One|October 8, 2011
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsKaren Chiam, Margaret M Centenera, Lisa M Butler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 7, 2007
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancerStephen N Birrell, Lisa M Butler, Jonathan M Harris, et al.
Pageof 19